WINTON GROUP Ltd Invests $329,000 in Sotera Health (NASDAQ:SHC)

WINTON GROUP Ltd acquired a new position in shares of Sotera Health (NASDAQ:SHC) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 24,049 shares of the company’s stock, valued at approximately $329,000.

Several other hedge funds have also made changes to their positions in the company. Blue Trust Inc. grew its holdings in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after buying an additional 1,140 shares during the last quarter. True Wealth Design LLC bought a new position in shares of Sotera Health during the third quarter valued at $32,000. GAMMA Investing LLC boosted its position in Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after buying an additional 1,121 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Sotera Health by 39.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company’s stock worth $127,000 after acquiring an additional 2,627 shares in the last quarter. Finally, iSAM Funds UK Ltd acquired a new position in Sotera Health in the third quarter worth $259,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on SHC. Barclays decreased their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research note on Friday, February 28th. The Goldman Sachs Group started coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 target price for the company. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Sotera Health Stock Performance

Shares of SHC opened at $11.77 on Monday. The firm has a market cap of $3.34 billion, a P/E ratio of 47.08 and a beta of 1.92. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm’s 50 day moving average price is $12.84 and its two-hundred day moving average price is $13.98.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.